Paul Cassanova-Romero

Publications by Year

Research Areas

Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer, Genetic Associations and Epidemiology, Liver Disease Diagnosis and Treatment

Most-Cited Works

• → Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study(2021)95 cited
• → The Impact of Physical Activity on the Prevention of Type 2 Diabetes: Evidence and Lessons Learned From the Diabetes Prevention Program, a Long-Standing Clinical Trial Incorporating Subjective and Objective Activity Measures(2020)69 cited
• → Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience(2022)29 cited
• → Association of Metformin With the Development of Age-Related Macular Degeneration(2022)24 cited
• → Identification of Genetic Variation Influencing Metformin Response in a Multiancestry Genome-Wide Association Study in the Diabetes Prevention Program (DPP)(2022)15 cited
• → The Diabetes Prevention Program and Its Outcomes Study: NIDDK’s Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact(2025)13 cited
• → Prevalence of Distal Symmetrical Polyneuropathy by Diabetes Prevention Program Treatment Group, Diabetes Status, Duration of Diabetes, and Cumulative Glycemic Exposure(2024)10 cited
• → The Effect of Interventions to Prevent Type 2 Diabetes on the Development of Diabetic Retinopathy: The DPP/DPPOS Experience(2022)10 cited
• → The 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) score and diabetes risk in the Diabetes Prevention Program Outcomes Study (DPPOS)(2022)4 cited
• → Longitudinal Metabolic Trajectories in Diabetes Prevention Program Participants Reveal Subgroups With Varying Micro- and Macrovascular Complication Risks(2025)2 cited